News | December 11, 2025
Roche secures CE mark for groundbreaking Vaginitis test that promises accurate diagnosis
Roche says its new assay “resolves this challenge by delivering accurate and specific results
Roche says its new assay “resolves this challenge by delivering accurate and specific results
76 of 180 long COVID-associated genes also linked to ME
StarGuide GX delivers ultra-high sensitivity and high-resolution imaging, enabling fast, confident diagnostics
Agreement adds a new preclinical ADC with potential for enhanced anti-tumour activity and best-in-class profile
Gazyva/Gazyvaro is the only anti-CD20 monoclonal antibody to demonstrate a complete renal response benefit in lupus nephritis in a randomised phase III study
New results from telisotuzumab adizutecan (Temab-A) and ABBV-706 demonstrate continued progress in AbbVie's antibody-drug conjugate (ADC) portfolio targeting difficult-to-treat cancers
Masitinib is targeted at patients who are no longer responding to hormone-sensitive prostate cancer treatments
Viatel bioresorbable polymers are increasingly used in dental and orthopedic implants
Aumolertinib can be used in patients who have tested positive for a mutation in a gene called epidermal growth factor receptor
DESTINY-Breast09 Phase III trial of AstraZeneca and Daiichi Sankyo’s Enhertu is the first trial in more than a decade to demonstrate superior efficacy across a broad HER2-positive metastatic patient population versus current 1st-line standard of care
Subscribe To Our Newsletter & Stay Updated
